The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness-Reference-Cited by-同舟云学术

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness

Published:2014-01-17 Issue:1 Volume:11 Page:
ISSN:1742-4690
Container-title:Retrovirology
language:en
Short-container-title:Retrovirology

Author:

Wares Melissa,Mesplède Thibault,Quashie Peter K,Osman Nathan,Han Yingshan,Wainberg Mark A

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Virology

Link

https://link.springer.com/content/pdf/10.1186/1742-4690-11-7.pdf

Reference31 articles.

1. Hightower KE, Wang R, DeAnda F, Johns BA, Weaver K, Shen Y, Tomberlin GH, Carter HL, Broderick T, Sigethy S: Dolutegravir (S/GSK1349572) exhibits significantly slower dissociation than raltegravir and elvitegravir from wild-type and integrase inhibitor-resistant HIV-1 integrase-DNA complexes. Antimicrob Agents Chemother. 2011, 55: 4552-4559. 10.1128/AAC.00157-11.

2. Wainberg MA, Mesplède T, Quashie PK: The development of novel HIV integrase inhibitors and the problem of drug resistance. Current Opinion in Virology. 2012, 2656: 662-

3. Quashie PK, Mesplède T, Wainberg MA: HIV drug resistance and the advent of integrase inhibitors. Curr Infect Dis Rep. 2013, 15: 85-100. 10.1007/s11908-012-0305-1.

4. Dyda F, Hickman AB, Jenkins TM, Engelman A, Craigie R, Davies DR: Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 1994, 266: 1981-1986. 10.1126/science.7801124.

5. Craigie R: HIV integrase, a brief overview from chemistry to therapeutics. J Biol Chem. 2001, 276: 23213-23216. 10.1074/jbc.R100027200.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive database of HIV mutations selected during antiretroviral in vitro passage experiments;Antiviral Research;2024-10

2. HIV-1 Integrase T218I/S Polymorphisms Do Not Reduce HIV-1 Integrase Inhibitors’ Phenotypic Susceptibility;AIDS Research and Human Retroviruses;2024-08-20

3. Insights in Dolutegravir-Resistance Pathways;Clinical Infectious Diseases;2024-03-11

4. Comprehensive Analysis of HIV-1 Integrase Resistance-Related Mutations in African Countries;Pathogens;2024-01-24

5. Comprehensive Database of HIV Mutations Selected During Antiretroviral in Vitro Passage Experiments;2024